ImmunityBio will submit long-term safety and efficacy data to the European Medicines Agency as part of the conditional ...

One of the more common complications is a ureteral obstruction, which is a blockage of the tubes that drain from the kidneys into the bladder. “The tumor can block the ability of urine to flow from ...

Draft guidance from NICE recommends durvalumab before and after surgery for muscle-invasive bladder cancer following phase 3 trial survival data.

(A) Schematic diagram of MPP@IKE-aPD-1/diABZI preparation. (B) Particle size of nanomedicine. (C) TEM images of MPP@IKE-aPD-1/diABZI nanomedicine incubated in different environments. Scale bar, 50 nm.

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

Investigators reported results from the first randomized controlled trial of office-based laser photocoagulation to standard TURBT for low-grade Ta bladder tumors.

The National Institute for Health and Care Excellence (NICE) published draft guidance recommending avelumab (Bavencio, Merck Serono) for the treatment of certain forms of bladder cancer. Adults with ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence for durvalumab, ...